186 related articles for article (PubMed ID: 26979012)
1. [Treatment of type 2 diabetes with metformin].
Amouyal C; Andreelli F
Rev Prat; 2015 Dec; 65(10):1245-9. PubMed ID: 26979012
[No Abstract] [Full Text] [Related]
2. [Diabetes drugs and body weight].
Eriksson J; Laine M
Duodecim; 2013; 129(1):73-8. PubMed ID: 23431885
[TBL] [Abstract][Full Text] [Related]
3. The target of metformin in type 2 diabetes.
Ferrannini E
N Engl J Med; 2014 Oct; 371(16):1547-8. PubMed ID: 25317875
[No Abstract] [Full Text] [Related]
4. Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
Derosa G; Salvadeo SA; D'Angelo A; Fogari E; Ragonesi PD; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
Arch Med Res; 2008 May; 39(4):412-9. PubMed ID: 18375253
[TBL] [Abstract][Full Text] [Related]
5. Metformin: a multitasking medication.
Bailey CJ
Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
[No Abstract] [Full Text] [Related]
6. Metformin: fifty-two not out.
Campbell IW
J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
[No Abstract] [Full Text] [Related]
7. [New clinical data with metformin therapy in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.
Ong CR; Molyneaux LM; Constantino MI; Twigg SM; Yue DK
Diabetes Care; 2006 Nov; 29(11):2361-4. PubMed ID: 17065668
[TBL] [Abstract][Full Text] [Related]
9. [Thus to avoid complications of diabetes. To combine early].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
[No Abstract] [Full Text] [Related]
10. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
11. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
Bosi E
Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
13. What's preventing us from preventing type 2 diabetes?
Fradkin JE; Roberts BT; Rodgers GP
N Engl J Med; 2012 Sep; 367(13):1177-9. PubMed ID: 23013070
[No Abstract] [Full Text] [Related]
14. [The rehabilitation of metformin].
Fernández Fernández I
Aten Primaria; 2005 Sep; 36(4):192-3. PubMed ID: 16153371
[No Abstract] [Full Text] [Related]
15. Metformin: a biguanide.
Tanja JJ; Langlass TM
Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
[TBL] [Abstract][Full Text] [Related]
16. Metformin and insulin meet in a most atypical way.
White MF
Cell Metab; 2009 Jun; 9(6):485-7. PubMed ID: 19490902
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.
Carter AM; Bennett CE; Bostock JA; Grant PJ
Diabet Med; 2005 Sep; 22(9):1282-4. PubMed ID: 16108864
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
19. [Renaissance of metformin].
Sieradzki J
Przegl Lek; 1999; 56(5):331-4. PubMed ID: 10554568
[TBL] [Abstract][Full Text] [Related]
20. Clinical decisions. Management of type 2 diabetes.
Goldberg RB; Holman R; Drucker DJ
N Engl J Med; 2008 Jan; 358(3):293-7. PubMed ID: 18199869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
